Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block listing Interim Review

3 Jan 2019 12:20

RNS Number : 1412M
Oxford Biomedica PLC
03 January 2019
 

For Immediate Release

3 January 2019

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 June 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

272,809

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

112,915

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

159,894

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 June 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

538,749

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

213,018

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

325,731

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 June 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

157,263

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

40,253

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

117,010

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 June 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

NIL

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

300,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

36,276

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

263,724

 

 

 

Name of contact:

Stuart Paynter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRUGURGGUPBGPW
Date   Source Headline
2nd Jun 20267:00 amRNSOXB Capital Markets Event
1st Jun 20267:00 amRNSTotal Voting Rights
27th May 20267:00 amRNSDirector Declaration
22nd May 20262:17 pmRNSDirector/PDMR Shareholding
19th May 20269:56 amRNSPDMR Dealing
13th May 202610:52 amRNSPDMR Dealing
7th May 20264:58 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20268:15 amRNSAdmission to Trading
27th Apr 20269:51 amRNSAdmission to Trading Application
13th Apr 20267:00 amRNS-RLaunch of viral vector fast-track offering
8th Apr 20265:18 pmRNSGrant of Awards
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20263:30 pmRNS2026 Annual General Meeting notification
26th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
18th Mar 20267:00 amRNS-RLicensing agreement with VVMF
9th Mar 20267:53 amRNSAdmission to Trading
4th Mar 202611:45 amRNSAdmission to Trading Application
3rd Mar 20267:00 amRNSCapital Markets Day and investor conferences
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20261:31 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
26th Feb 20261:49 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 202612:33 pmRNSForm 8.3 - Oxford Biomedica plc
26th Feb 202611:09 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
26th Feb 202611:08 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
26th Feb 20269:42 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica plc
25th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
25th Feb 20262:32 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
25th Feb 202612:33 pmRNSResponse to Rule 2.8 Announcement
25th Feb 202612:12 pmRNSDisclosure Table
25th Feb 202612:00 pmRNSRule 2.8 Announcement
25th Feb 202611:46 amRNSForm 8.3 - Oxford Biomedica plc
25th Feb 202610:53 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica Plc
25th Feb 202610:17 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
25th Feb 202610:15 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
24th Feb 20267:29 amRNSForm 8.5 (EPT/RI)-Oxford Biomedica plc
24th Feb 20267:25 amRNSForm 8.5 (EPT/NON-RI)-Oxford Biomedica plc
24th Feb 20267:03 amRNSFull year Trading Update and Notice of Results
23rd Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
23rd Feb 20262:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc
23rd Feb 20267:40 amRNSForm 8.5 (EPT/RI)-Oxford Biomedica plc
23rd Feb 20267:39 amRNSForm 8.5 (EPT/NON-RI)-Oxford Biomedica plc
20th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20268:13 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
20th Feb 20268:08 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
19th Feb 20262:39 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
19th Feb 20269:44 amRNSRule 2.9 Announcement
19th Feb 20268:04 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.